Anna Petit
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 17
- Cancer Genomics and Diagnostics 2
- Oncology 8
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Carme Mallofré (5 shared papers)Mireia Castillo-Martín (4 shared papers)Begoña Mellado (3 shared papers)Mònica Santos (1 shared paper)Antonio Palacı́n (1 shared paper)Catalina Falo (8 shared papers)Irene Sansano (1 shared paper)José Ramón Antúnez López (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (6 papers)Nature Communications (2 papers)Cancers (2 papers)Frontiers in Oncology (2 papers)Breast Cancer Research (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Anna Petit
37 papers receiving 965 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 263
- Oncology 136
- Cell Biology 71
- Pulmonary and Respiratory Medicine 145
- Aging 6
Countries citing papers authored by Anna Petit
This map shows the geographic impact of Anna Petit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Petit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Petit more than expected).
Fields of papers citing papers by Anna Petit
This network shows the impact of papers produced by Anna Petit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Petit. The network helps show where Anna Petit may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Petit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 177 | |
| 2 | 2017 | 129 | |
| 3 | 2019 | 95 | |
| 4 | 2013 | 81 | |
| 5 | 2004 | 79 | |
| 6 | 2004 | 49 | |
| 7 | 2015 | 35 | |
| 8 | 2022 | 34 | |
| 9 | 2018 | 33 | |
| 10 | 2021 | 20 | |
| 11 | 2023 | 19 | |
| 12 | 2018 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2012 | 17 | |
| 15 | 2019 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2015 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2021 | 12 | |
| 20 | 2016 | 11 |
About Anna Petit
Anna Petit is a scholar working on Cancer Research, Oncology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 993 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), BRCA gene mutations in cancer (5 papers), Renal cell carcinoma treatment (4 papers), Breast Lesions and Carcinomas (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers) and Tuberous Sclerosis Complex Research (2 papers). The work is most often cited by research in Cancer Research (263 citations), Oncology (136 citations), Cell Biology (71 citations), Pulmonary and Respiratory Medicine (145 citations) and Aging (6 citations). Anna Petit has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Carme Mallofré, Mireia Castillo-Martín, Begoña Mellado, Mònica Santos, Antonio Palacı́n, Catalina Falo, Irene Sansano, José Ramón Antúnez López, Martin Espinosa-Bravo and Isabel Teresa Rubio. Their work appears in journals such as Breast Cancer Research and Treatment, Nature Communications, Cancers, Frontiers in Oncology and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.